Tag: FDA
AstraZeneca Vaccine Controversy Provides Another Example of Overly Cautious Government Reactions

After a sluggish and error-prone beginning to a country-wide effort to vaccinate Americans against Covid-19, it seems things are quickly improving.  According to the Centers for Disease Control, as of March 18th, nearly 113 million Americans have received at least Covid-19 vaccination (two of the three available vaccines require two separate injections). The agency...
Read More »

The FDA Should Grant Emergency Use Authorization for Alzheimer’s Drug

In March 2019, an experimental drug designed to treat Alzheimer’s disease named aducanumab failed a futility test during the process for approval from the Food and Drug Administration. Facing seemingly little hope for success, aducanumab’s producers Biogen and Eisai strongly considered abandoning the project. However, when the drugmakers conducted further analysis on a larger...
Read More »

New COVID-19 Vaccines, Same Sluggish FDA

In October, large portions of the United States began experiencing rapid increases in new COVID-19 cases. Many European countries have experienced a similar surge in cases, even after being devastated by severe COVID-19 outbreaks earlier this year. Fearing the arrival of a second wave, several states reenacted various lockdown measures to curb spreading disease....
Read More »

FDA Approves Blood Plasma as Covid-19 Treatment

In the nearly eight months since Covid-19 arrived in the United States, the country has undergone extensive lockdowns, trying economic hardship, and prolonged social isolation. Despite these sacrifices to battle the pandemic, the U.S. continues to lead the world in total confirmed Covid-19 cases and Covid-19 fatalities. As of September 9, the Coronavirus Resource...
Read More »

Promising Alzheimer’s Drug on FDA Fast Track

Well before Covid-19 emerged, medical researchers warned that the rapid increase of Alzheimer’s disease in older populations would lead to the next “pandemic.” In many respects, they were right. According to the Alzheimer’s Association, nearly 10 percent of the U.S. population over 65 years old suffers from that progressively destructive brain disorder. The same...
Read More »

To Make Drugs More Affordable, President Trump Should Focus on Price Competition

President Trump has tried seemingly everything to lower prescription drug prices. In 2018 alone, he established an international pricing index to prevent overcharging from foreign drug producers, targeted drug rebates between producers and middlemen, and granted Medicare Part D plans more authority to negotiate drug prices. Despite these and other efforts, the prices for thousands of...
Read More »

Keep Government Out of Developing a COVID-19 Vaccine

In late March, California became the first state to issue mandatory “shelter in place” orders. By mid-April, nearly 94 percent of the U.S. population was under order to stay at home. Nearly three months later, millions are still desperate to get back to their lives. Protest rallies held to “reopen the economy” have emerged...
Read More »

More Executive Orders Will Not Fix Healthcare

Draconian measures to “flatten the curve” were implemented to prevent the healthcare sector from becoming overwhelmed with infected patients. Now, as many states reopen for business, it seems relatively few healthcare facilities are overwhelmed. However, much of the healthcare industry is still struggling. Becker Hospital Review finds that more than 250 hospitals are furloughing...
Read More »

Cut Regulations and Get COVID-19 Drugs to Patients

As the coronavirus pandemic continues to ravage the U.S. healthcare system, many healthcare professionals are struggling to find enough medical supplies to treat patients and to avoid becoming infected themselves. A recent New York Post article finds nurses working in a New York City hospital resorted to covering themselves with garbage bags because the...
Read More »

Right-to-Try Laws Can Help Drugmakers Combat the Coronavirus

President Trump recently announced he is extending social distancing guidelines to April 30th. He initially hoped to lift them by Easter. This is far from the first time he has changed his mind on how to best handle the coronavirus pandemic. Although frustrating, the President’s indecisiveness is understandable. The United States recently surpassed China...
Read More »

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org